Bliss GVS Pharma allots shares under ESOP-2019 plan

Bliss GVS Pharma Limited announced on August 29, 2025, the allotment of 38,000 equity shares to eligible employees under its Bliss GVS ESOP-2019 plan. Each share has a face value of Re. 1/- and was issued at an exercise price of Rs. 43/-, with a premium of Rs. 42/- per share.

This allotment increases the company's issued, subscribed, and paid-up share capital from 10,55,71,523 equity shares to 10,56,09,522 equity shares, aggregating Rs. 10,56,09,522/-. The newly issued shares, with distinctive numbers from 10,55,71,523 to 10,56,09,522, will be locked in for a period of six months, expiring on February 28, 2026.

All allotted equity shares will rank pari-passu with the existing equity shares of the company. This move aligns with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.